ProCE Banner Activity

BTK Inhibitors for Relapsed/Refractory Chronic Lymphocytic Leukemia

Slideset Download
Download this slideset from John Pagel, MD, PhD for the most up-to-date data on therapy for patients with R/R CLL, including novel approaches that may impact clinical practice in the near future.

Released: December 04, 2020

Expiration: December 03, 2021

No longer available for credit.

Share

Faculty

John Pagel

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Faculty Disclosure

Primary Author

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington